68Ga-PMD22(Peking Union Medical College Hospital)

N/A

Report date: 2025/11/21 17:16:37

Base Information

Drug Name68Ga-PMD22(Peking Union Medical College Hospital)

Drug Alias NameCLDN18.2 Targeted 68Ga-PMD22(Peking Union Medical College Hospital)

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionClaudin 18 protein modulators

TargetsClaudin-18 splice variant 2

Therapy Area/IndicationsGastrointestinal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesPeking Union Medical College Hospital

China Registration ClassN/A

Develop Information

Active CompaniesPeking Union Medical College Hospital

Inactive CompaniesN/A

Active IndicationsGastrointestinal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A